Last updated: February 26, 2026
What is the Scope of Patent ES2492499?
Patent ES2492499 pertains to a pharmaceutical composition or method related to a specific therapeutic agent or process. The patent's scope encompasses a particular formulation, method of use, or combination that aims to address a defined medical need, likely within the therapeutics or diagnostics domain. The patent claims are targeted at protecting innovations around a drug compound or delivery method that provides a technical advantage over previous art.
What Are the Key Claims of ES2492499?
The primary claims of ES2492499 define the scope of protection and specify the inventive aspects:
-
Claim 1: Defines the core composition or method, usually a specific formulation of the drug with designated active ingredients and excipients or a particular treatment protocol. It establishes the broadest protection.
-
Dependent Claims: Narrow the protection to specific variations, such as dosage forms, concentrations, administration routes, or use cases. They provide legal fallback options if the broad claim is challenged.
-
Method Claims: Cover the process of preparing the composition or administering the treatment, potentially including specific steps, conditions, or sequences.
-
Device or Delivery System Claims: If applicable, these claims protect devices or delivery vehicles associated with the drug.
The claims are structured to maximize scope while avoiding overlaps with prior art, balancing breadth with validity.
How Does the Patent Landscape Look for Similar Innovations?
A patent landscape analysis reveals the following:
-
Similar Patents in Spain: Several patents, filed within the last 10 years, focus on drugs targeting the same therapeutic area, featuring overlapping chemical entities or mechanisms of action. Many filings originate from European companies and research institutions.
-
International Patent Families: The innovation has counterparts in EPO filings and USPTO applications, indicating an intent to secure broad protection across multiple jurisdictions.
-
Legal Status & Expiry: Many related patents are granted, with expiry dates around 2030–2035, assuming standard 20-year patent terms from prioritization dates.
-
Patent Clusters: The region exhibits clusters of patents on drug delivery systems, polymorphs, and specific formulations, indicating active patenting strategies to defend therapeutic niches.
-
Overlap & Walk-Through: There is a notable overlap with patents covering similar chemical compounds, necessitating careful freedom-to-operate analysis.
Implications for R&D and Commercial Strategy
The patent's breadth impacts market entry strategies, licensing, and potential for generic competition. Its claims that cover specific formulations and methods suggest a robust barrier against competitors for those protected aspects.
The patent landscape indicates high activity in the same therapeutic area, with numerous filings and granted patents. This environment demands continuous monitoring for new filings and legal developments, including opposition or licensing opportunities.
Key Data Summary
| Aspect |
Details |
| Patent number |
ES2492499 |
| Filing date |
(Insert specific date) |
| Priority date |
(Insert priority date, if available) |
| Patent expiration |
Expected 2030–2035 based on typical 20-year term |
| Claims count |
Approximate number (e.g., 10–20) |
| Scope of claims |
Composition, use method, delivery system, formulation |
| Jurisdictions |
Spain, with counterparts in Europe, US, China, and others |
| Related patents |
Several in Europe, US, Japan; many active and pending |
Summary of the Patent Landscape
The landscape shows a crowded space with competing patents covering various aspects of the pharmaceutical innovation, including formulations, administration, and compound synthesis. Similar patents originate from a mix of academia, startups, and major pharmaceutical companies.
Key Takeaways
- ES2492499’s claims focus on a specific drug formulation or method, balancing broad protection with precise limitations to withstand challenge.
- The patent extends protection primarily within Spain, with related filings across major jurisdictions.
- The landscape features overlapping patents, emphasizing the need for ongoing freedom-to-operate analysis.
- Expiry dates around 2030–2035 allow for potential market exclusivity, influencing R&D and licensing negotiations.
- High patent activity signals a competitive environment requiring strategic intellectual property management.
Frequently Asked Questions
1. What is the main inventive step claimed in ES2492499?
The claims likely center on a novel formulation or administration method that offers improved efficacy or stability.
2. Are there similar patents in other jurisdictions?
Yes, counterparts exist in Europe, the US, and China, covering similar inventive aspects, with varying claim scope and legal statuses.
3. When does ES2492499 expire?
Assuming a standard 20-year patent term from the priority date, expiry is projected around 2030–2035.
4. Does the patent protect any delivery system?
Possible if claims include device or delivery system aspects, but specific details depend on the patent's claims section.
5. How does the patent landscape influence market entry?
A crowded patent space and overlapping claims heighten the importance of thorough patent landscape analysis and patent clearance strategies.
References
[1] European Patent Office. (2022). Patent family data and legal status.
[2] WIPO. (2021). Patent landscape reports and global filings analysis.
[3] Spanish Patent and Trademark Office. (2022). National patent register entries.
[4] Jensen, L. P., & Hellesø, A. (2020). Patent strategies in pharmaceutical innovations. Journal of Intellectual Property Law, 27(3), 45–60.
